US Housing Market Faces Setback Amid Rising Mortgage Rates

US Housing Market Faces Setback Amid Rising Mortgage Rates

In a recent report from Reuters, the U.S. single-family homebuilding sector has hit an eight-month low in June, largely due to escalating mortgage rates. This downturn suggests a potential drag on the nation’s economic growth during the second quarter.

Single-family housing starts saw a decline of 2.2%, while building permits for future construction decreased by 2.3%, reaching a one-year low. This trend indicates that any anticipated recovery in the housing market, even with expected interest rate cuts by the Federal Reserve later this year, might be subdued.

Despite these challenges, the housing market continues to grapple with a shortage of previously owned homes, which keeps prices elevated. The higher mortgage rates, which had peaked above 7% earlier this year, have dampened the construction momentum seen in previous months.

Manufacturing Sector Shows Promise

Contrasting with the housing market’s struggles, the manufacturing sector has shown signs of recovery. Manufacturing production increased by 0.4% in June, signaling emerging positive trends within this interest-rate-sensitive sector.

According to a separate report from the Federal Reserve, motor vehicle production surged to a nine-year high, contributing to the overall increase in factory output.

Economic Outlook and Implications

Economists forecast a mixed impact on the residential construction sector from upcoming interest rate adjustments. While the Atlanta Fed projects a 2.7% annualized GDP growth rate for the second quarter, there are concerns that rising unemployment could curb the flow of new buyers, even if mortgage rates decrease.

The multifamily housing market continues to benefit from a shift towards renting, with permits for multi-unit projects seeing a significant increase. This trend further highlights the complexities and challenges within the current housing market landscape.

For more insights into the day ahead in U.S. and global markets, consider subscribing to the Morning Bid U.S. newsletter.

Leave A Comment

Total Views: 12Daily Views: 0By Categories: Article, Economic Growth, Housing MarketTags: , Published On: October 31, 2024Last Updated: October 31, 2024

Review This Page

Recent Posts

  • Digital illustration of 3D DNA strands in an abstract blue background

CRISPR: The Future of Gene Editing and Its Clinical Implications

December 1, 2024|0 Comments

CRISPR technology has become the frontrunner in genome editing, surpassing earlier methods like zinc finger nucleases and transcription activator-like effector nucleases. The recent FDA approval of the CRISPR-Cas9 drug, exa-cel, marks a significant milestone particularly for treating sickle cell disease and transfusion-dependent beta thalassemia.